Can Wei
Impact in
- Developmental Neuroscience top 5%
- Anesthesia and Neurotoxicity Research
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- Polyamine Metabolism and Applications 10
- Renal and related cancers 3
- Gut microbiota and health 3
-
- Cardiac Ischemia and Reperfusion 8
- Co-authors
- Ling Fang (4 shared papers)Changqing Xu (19 shared papers)Jiahao Li (2 shared papers)Siyu Yuan (2 shared papers)Lijun Zhang (2 shared papers)Guofang Liu (2 shared papers)Lingling Li (2 shared papers)Jing Li (5 shared papers)
- Journals
- Cell Biology International (3 papers)Basic Research in Cardiology (3 papers)Phytotherapy Research (2 papers)International Journal of Molecular Medicine (2 papers)mSystems (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Can Wei
60 papers receiving 1.9k citations
Can Wei's Hit Papers
Peers
Comparison fields: 5 of 129
- Developmental Neuroscience 168
- Cancer Research 288
- Pathology and Forensic Medicine 326
- Emergency Medicine 141
- Geriatrics and Gerontology 47
Countries citing papers authored by Can Wei
This map shows the geographic impact of Can Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Wei more than expected).
Fields of papers citing papers by Can Wei
This network shows the impact of papers produced by Can Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Wei. The network helps show where Can Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF‐1α/SLC7A11 pathway Hit paper breakdown → | 2021 | 316 |
| 2 | 2014 | 198 | |
| 3 | 2020 | 94 | |
| 4 | 2012 | 94 | |
| 5 | 2022 | 71 | |
| 6 | 2018 | 62 | |
| 7 | 2020 | 55 | |
| 8 | 2015 | 54 | |
| 9 | 2017 | 52 | |
| 10 | 2014 | 49 | |
| 11 | 2023 | 49 | |
| 12 | 2020 | 49 | |
| 13 | 2014 | 40 | |
| 14 | 2020 | 39 | |
| 15 | 2016 | 37 | |
| 16 | 2017 | 36 | |
| 17 | 2013 | 31 | |
| 18 | 2024 | 29 | |
| 19 | 2021 | 29 | |
| 20 | 2020 | 27 |
About Can Wei
Can Wei is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Surgery, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 66 papers that have together received 1.9k indexed citations. Recurring topics across this work include Polyamine Metabolism and Applications (10 papers), Cardiac Ischemia and Reperfusion (8 papers), Sulfur Compounds in Biology (5 papers), Cannabis and Cannabinoid Research (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Renal cell carcinoma treatment (3 papers), Renal and related cancers (3 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Developmental Neuroscience (168 citations), Cancer Research (288 citations), Pathology and Forensic Medicine (326 citations), Emergency Medicine (141 citations) and Geriatrics and Gerontology (47 citations). Can Wei has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Ling Fang, Changqing Xu, Jiahao Li, Siyu Yuan, Lijun Zhang, Guofang Liu, Lingling Li, Jing Li, Andrew N. Redington and Hongzhu Li. Their work appears in journals such as Cell Biology International, Basic Research in Cardiology, Phytotherapy Research, International Journal of Molecular Medicine and mSystems.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.